Sign in
CompletedPhase 1

Bioequivalence study on aqueous humour concentrations of active ingredients after topical application of LEVIOSA® versus F2904. Randomized, parallel-group, blinded-assessor study in patients undergoing cataract surgery – BreAK Free

Key facts

Who runs it
Ntc S.r.l.
Where
Italy3 sites in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
90 people enrolled
Started
22 Apr 2024
Ended
20 Mar 2025
Type of study
Interventional
Record updated
19 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

Where is this trial?

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
19 December 2024